Jay Schachner

Statistics

Publications

Citations

563

H-Index

Active since

1988

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Anderson Hospital

Jay Schachner is an author at The University of Texas MD Anderson Cancer Center specializing in hematologic malignancy therapy, medicine, and chemotherapy.

Publications per year

1988–1991

Publications

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.

Michael J. Keating, H. Kantarjian, S O'Brien et al. · Journal of Clinical Oncology · 1991 · 249 citations

Medicine, Oncology, Pharmacology +14

Fludarabine therapy in hairy cell leukemia

Hagop M. Kantarjian, Jay Schachner, Michael J. Keating · Cancer · 1991 · 60 citations

Medicine, Pharmacology, Pharmacotherapy +12

Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia

Hagop M. Kantarjian, Craig C. Childs, Susan O’Brien et al. · The American Journal of Medicine · 1991 · 55 citations

Medicine, Oncology, Pharmacology +16

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia

Hagop M. Kantarjian, Ronald Walters, Michael J. Keating et al. · Cancer · 1990 · 51 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy.

M Shtalrid, Moshe Talpaz, Mark Blick et al. · Journal of Clinical Oncology · 1988 · 49 citations

Life Sciences, Hematology, Molecular Biology +13

1–5 of 9